跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aβ inhibitor
首页
药物
Aβ inhibitor
Aβ inhibitor
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GENE THERAPY FOR TREATING NEURODEGENERATIVE DISEASES
EP 4286521 A4
申请人: ABRAIN
优先权: 2021
EP
US
WO
3 件公开
Isoindol-sulfilimine compound and use as a sigma-2 receptor inhibitor thereof
US 20250236591 A1
申请人: SHANGHAI UNIV OF MEDICINE AND HEALTH SCIENCES
优先权: 2024
US
WO
3 件公开
USE OF FACTOR H FOR THE TREATMENT OF DEMENTIA
EP 4794711 A1
申请人: INST NAT SANTE RECH MED
优先权: 2023
EP
WO
2 件公开
DUAL-DRUG NANOPARTICLE FOR TREATING ALZHEIMER'S DISEASE, METHOD FOR PREPARING SAME, AND USE THEREOF
WO 2026152919 A1
申请人: UNIV CHINA PHARMA
优先权: 2025
CN
WO
2 件公开
Oxidized Aβ peptide
US 10035831 B2
申请人: JAPAN SCIENCE & TECH AGENCY
优先权: 2013
US
2 件公开
Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
US 10016414 B2
申请人: MORABITO MARIA
优先权: 2011
US
Compositions and methods for treating an Aβ-modulated disease or disorder or improving cognition in a subject
US 10660957 B2
申请人: UNIV YALE
优先权: 2014
US
Method for screening drug and therapeutic targets used for treating Alzheimer's disease
US 11236378 B2
申请人: JIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD
优先权: 2015
US
Application of PI4KIIIA protein and related membrane protein complex in treating alzheimer's disease
US 11766420 B2
申请人: JIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD
优先权: 2015
US
Compositions and methods for improving cognition in a subject
US 11241434 B2
申请人: UNIV YALE
优先权: 2020
US
第 1 / 2 页
上一页
下一页
药物
反馈